Document is current
Any future updates will be listed below
-
Authors
Wani, Said https://orcid.org/0009-0008-7337-494X
Alsabti, Hilal
Allamki, Said
Almandhari, Ahmed
Alhajji, Suleiman
Alrashdi, Ibrahim
Alsabri, Raid
Alqassabi, Adnan
Alzaabi, Ahmed
Almaashani, Aisha
Alshuaili, Alia
Rasool, Anisa
Alkindi, Asiya
Salman, Bushra
Alzadjali, Faiza
Alrahbi, Khalid
Almutawa, Khulood
Alansari, Manal
Alkharusi, Mardheya
Albulushi, Nadiya
Alghadani, Rahma
Aljaber, Rana
Almuaini, Safiya
Alkindi, Said
Alzawamri, Salim
Albalushi, Sara
Allawati, Suha
Alsalti, Zuhair
Albalushi, Hassan
Fasseeh, Ahmad Nader
Kalo, Zoltan
-
Funding
Funding for this research was provided by:
Semmelweis University
- License Information
-
More Information
Article History
Received: 27 November 2025
Accepted: 1 July 2026
First Online: 15 July 2026
Declarations
Ethics approval and consent to participate: Not required.
Consent for publication: Not applicable.
Competing interests: Syreon Middle East acknowledges Novartis for its financial support in conducting the study. Ahmad Nader Fasseeh and Zoltán Kaló are shareholders in Syreon Middle East. The remaining authors declare that the research was conducted without any commercial or financial relationships that could be seen as a potential conflict of interest. The funder was not involved in the study design, data collection, data analysis, data interpretation, or manuscript writing.
